Related Experiment Videos
Recognizing and managing patients with irritable bowel syndrome
Anne Croghan1, Margaret M Heitkemper
1Seattle Gastroenterology Associates, Seattle, Washington, USA. acroghan@u.washington.edu
Journal of the American Academy of Nurse Practitioners
|February 18, 2005
Summary
Diagnosing irritable bowel syndrome (IBS) relies on symptom assessment and communication. Red flag symptoms may necessitate further testing to rule out organic conditions, with serotonin playing a key role.
Area of Science:
- Gastroenterology
- Neurogastroenterology
Background:
- Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder.
- Pathophysiology involves gut motility and visceral sensitivity.
- Serotonin (5-HT) is implicated in IBS mechanisms.
Purpose of the Study:
- To outline diagnostic criteria for IBS.
- To discuss clinical management strategies for IBS.
- To review available serotonergic agents for IBS treatment.
Main Methods:
- Literature review of recent studies on IBS pathophysiology.
- Analysis of diagnostic approaches for IBS.
- Evaluation of pharmacological treatments, focusing on serotonergic agents.
Main Results:
- IBS diagnosis is primarily symptom-based, requiring thorough patient history and examination.
- Alarm symptoms warrant diagnostic testing to exclude organic disease.
- Serotonin significantly influences gut function and pain perception in IBS.
Conclusions:
- Effective clinician-patient communication is crucial for accurate IBS diagnosis.
- Diagnostic testing is indicated for IBS patients with red flag symptoms.
- Serotonergic agents represent a key therapeutic option for managing IBS.